The medication contains semaglutide, a GLP-1 receptor agonist that helps regulate blood sugar levels, reduce appetite, and promote a sense of fullness
The pill is licensed for adults with obesity (a BMI of 30 or above), or who are overweight (a BMI of 27 to 30) with at least one weight-related condition, alongside a reduced-calorie diet and more physical activity
This dual action boosts insulin release, helps manage fat storage, makes you feel fuller longer, reduces appetite, and helps you lose weight faster
The central mechanism investigated in Epithalon research is its effect on telomerase activity
Be careful when choosing an online provider
These are real differences that affect the regulatory review, quality oversight, and liability structure behind what you receive